NDAORALTABLETPriority Review
Approved
Dec 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
17
Data completeness
5/8 — Partial
Priority Review
LIPITOR (atorvastatin calcium) by Viatris is selective, competitive inhibitor of hmg-coa reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methylglutaryl-coenzyme a to mevalonate, a precursor of sterols, including cholesterol. First approved in 1996.
Drug data last refreshed 8h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LIPITOR (atorvastatin calcium) is an oral small-molecule statin that selectively inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis. It reduces LDL cholesterol and lipoprotein levels by decreasing hepatic cholesterol production and increasing LDL receptor-mediated uptake. LIPITOR is indicated for patients with elevated cholesterol and cardiovascular risk.
$0.033BPart D
LOE ApproachingDeclining
Product approaching loss of exclusivity with moderate Medicare utilization; team focus shifts from growth to lifecycle extension and generic preparation strategies.
Mechanism of Action
selective, competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methylglutaryl-coenzyme A to mevalonate, a precursor of sterols, including cholesterol. In animal models, LIPITOR lowers plasma cholesterol and lipoprotein levels by inhibiting HMG-CoA…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (17)
Bioequivalence Study Between "Dong-A Atorvastatin Tab" and "Lipitor Tab"
Started Mar 2020
56 enrolled
Healthy
Actual Use Trial of Atorvastatin Calcium 10 mg
Started Oct 2013
1,311 enrolled
Hypercholesterolemia
Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fasting Condition
Started Oct 2011
80 enrolled
Healthy
Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fed Condition
Started Sep 2011
90 enrolled
Healthy
Special Drug Use-Results Survey of Lipitor Tablets
Started Sep 2010
24,050 enrolled
Hypercholesterolemia
Worked on LIPITOR at Viatris? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.